Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials

被引：0
|
作者：
B-B. Qian
Q. Chen
L. Li
C-F. Yan
机构：
[1] The Second Clinical College of Dalian Medical University,Department of Endocrinology, Northern Jiangsu People’s Hospital
来源：
Osteoporosis International | 2020年 / 31卷
关键词：
Fracture; Meta-analysis; Metformin; Type 2 diabetes mellitus; SGLT2 inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2313 / 2320
页数：7
相关论文
共 50 条
  • [1] Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials
    Qian, B-B
    Chen, Q.
    Li, L.
    Yan, C-F
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (12) : 2313 - 2320
  • [2] Comparative Cardiovascular Outcomes of SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Controlled Trials
    Jiang, Yu
    Yang, Pingping
    Fu, Linghua
    Sun, Lizhe
    Shen, Wen
    Wu, Qinghua
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [3] The efficacy and safety of SGLT2 inhibitors combined with ACEI/ARBs in the treatment of type 2 diabetes mellitus: A meta-analysis of randomized controlled studies
    Cai, Yuwen
    Shi, Weinan
    Xu, Gaosi
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (11) : 1497 - 1504
  • [4] Efficacy and Safety of SGLT2 Inhibitors in Patients with Type 1 Diabetes:A Meta-analysis of Randomized Controlled Trials
    Yingying Yang
    Hui Pan
    Bo Wang
    Shi Chen
    Huijuan Zhu
    [J]. Chinese Medical Sciences Journal, 2017, 32 (01) : 22 - 27
  • [5] SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
    Tang, Huilin
    Dai, Qi
    Shi, Weilong
    Zhai, Suodi
    Song, Yiqing
    Han, Jiali
    [J]. DIABETOLOGIA, 2017, 60 (10) : 1862 - 1872
  • [6] SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
    Huilin Tang
    Qi Dai
    Weilong Shi
    Suodi Zhai
    Yiqing Song
    Jiali Han
    [J]. Diabetologia, 2017, 60 : 1862 - 1872
  • [7] Association of SGLT2 Inhibitors With Risk of Atrial Fibrillation and Stroke in Patients With and Without Type 2 Diabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
    Zheng, Ru-Jie
    Wang, Yue
    Tang, Jun-Nan
    Duan, Jie-Ying
    Yuan, Ming-Yue
    Zhang, Jin-Ying
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 145 - 152
  • [8] Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
    Yang, Shiwen
    Liu, Ying
    Zhang, Shengzhao
    Wu, Fengbo
    Liu, Dan
    Wu, Qingfang
    Zheng, Hanrui
    Fan, Ping
    Su, Na
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Li, Wen-jie
    Chen, Xing-qing
    Xu, Ling-ling
    Li, Yuan-qing
    Luo, Bi-hui
    [J]. CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [10] Renal outcomes in Asian patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
    Shi-di Zhao
    Ling Zhou
    Yi-ying Tao
    Yue Yue
    Jia-xin Wang
    Lei Shen
    Guo-yuan Lu
    Yong-fu Hang
    [J]. International Journal of Diabetes in Developing Countries, 2022, 42 : 178 - 190
12345